By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1bis, rue de l’Internationale

Evry  Cedex  91002  France
Phone: 33-0-1-69-47-28-28 Fax: n/a



Company News
CEVEC Pharma And Genethonn Sign A Collaboration Agreement To Develop Lentiviral Vector Packaging Cell Lines Based On CEVEC's Proprietary CAP(R)GT Technology 9/17/2015 8:46:19 AM
Audentes Therapeutics And Genethon Announce Agreement To Develop Treatment For Severe Genetic Disease X-Linked Myotubular Myopathy 2/5/2014 9:00:29 AM
Genethon, the French AFM-Telethon Laboratory, Becomes the First Not-for-Profit to Obtain Authorization From ANSM to be a Pharmaceutical Manufacturer 7/9/2013 9:30:36 AM
Genethon Receives Approval From the UK Medicine Regulatory Agency to Start a New Clinical Trial for an Inherited Immune Deficiency: Chronic Granulomatous Disease 2/5/2013 12:14:59 PM
Genethon Receives the 2012 Galien Prize for its Innovative Treatments in Gene Therapy 10/4/2012 2:38:03 PM
Alain Schwenck, an Expert on Pharmaceutical Production, Becomes Director of Genethon Bioprod 7/5/2012 8:59:49 AM
Fulvio Mavilio, the Internationally Acknowledged Expert in Gene Therapy for Rare Diseases, is Appointed as Genethon's New Scientific Director 1/17/2012 10:35:27 AM
Genethon, AFM: Encouraging Results in a Phase I Clinical Trial in Limb-Girdle Muscular Dystrophy Type 2C 1/12/2012 9:22:01 AM
Genethon and Children's Hospital Boston Get FDA Approval for a Wiskott Aldrich Gene Therapy Trial 7/21/2011 10:47:30 AM
Genethon and Wake Forest University School of Medicine (North Carolina) Announce their Collaboration for a Preclinical Gene Therapy Trial 3/8/2011 9:55:16 AM